ICARES Medicus, Inc. (TPEX:6612)
127.50
+1.00 (0.79%)
Feb 21, 2025, 1:30 PM CST
ICARES Medicus Company Description
ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally.
The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services.
It also provides nanomedical lubricious coatings and various surface treatments for implantable and interventional medical devices.
ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei City, Taiwan.
ICARES Medicus, Inc.
Country | Taiwan |
Founded | 2011 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Ih-Houng Loh |
Contact Details
Address: No. 16, Shengyi Road Zhubei City, 30261 Taiwan | |
Phone | 886 3 657 9530 |
Website | icaresmedicus.com |
Stock Details
Ticker Symbol | 6612 |
Exchange | Taipei Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | TW0006612005 |
SIC Code | 3851 |
Key Executives
Name | Position |
---|---|
Dr. Ih-Houng Loh | Chairman and Chief Executive Officer |
Wen-Chu Tseng | Chief Research & Development Officer and Vice Chairman |
William Lee | President, Research & Development Supervisor and Director |
Tan-Li Chen | Vice President and Spokesperson of Finance and Accounting Department |
Junming Lin | Vice President of Research & Development and Operations |
Carl Robert Cummings | President of Major Subsidiary |
Ying-Zong Yan | Director |